May 17, 2016

Posted by in Stock Reports | 0 Comments

Significant Insider Buying Activity: Cenveo, Inc. (NYSE:CVO), ChemoCentryx Inc (NASDAQ:CCXI), The Medicines Company (NASDAQ:MDCO)

Significant Insider Buying Activity: Cenveo, Inc. (NYSE:CVO), ChemoCentryx Inc (NASDAQ:CCXI), The Medicines Company (NASDAQ:MDCO)

As a general rule, insider buying shows management’s confidence in the company, and is considered a bullish sign—in other words a sign that stock prices are likely to go up. Conversely, insider selling is considered bearish—those in the know may be off loading their stocks in an expectation that prices will soon fall. So it pays to keep an eye on the activities of insiders.

Studies have shown that prompt and timely dissemination of insider transactions are profitable for investors, as insiders tend to beat the market. The odds in favor of an insider purchase being followed by further purchases are three times greater than the odds of a purchase followed by a sale.

Moving on to the first insider trade May 12, 2016 which involved Burton Michael G, a Chief Operating Officer at Cenveo, Inc. (NYSE:CVO), who acquired 111,112 shares at $0.90 per share to put the total holding at 751,704 shares. Its shares currently owned by company management are 10.10% while institutional investors own about 60.60%. The 6-month change recorded in total insider ownership was 2.47%. On the other side, -3.36% change in total institutional ownership has been reported for the 3-month period.

ChemoCentryx Inc (NASDAQ:CCXI) saw an insider buy stock in the company on May 16. Edwards Thomas A., director of the company, bought 25,000 shares for $4.05 per share worth a total of $101,213. After this insider buying, Edwards Thomas A. now has a total stake of 41,977 shares in the company. Its shares currently owned by company management are 4.90% while institutional investors own about 62.20%. The 6-month change recorded in total insider ownership was 1.15%. On the other side, -4.06% change in total institutional ownership has been reported for the 3-month period.

The Medicines Company (NASDAQ:MDCO) also received some insider trading action as WYATT ELIZABETH H S, who is the company’s director added some 4,153 shares at a price of $34.00 per share to the holding that now comprises of 38,970 shares. Its shares currently owned by company management are 1.00%. The 6-month change recorded in total insider ownership was 62.30%. On the other side, 0.56% change in total institutional ownership has been reported for the 3-month period.

 

 

 

 

Comments are closed.